Alexandros Sigalas

Vifor Pharma AG is a pharmaceutical company, which engages in the research, development, production, and marketing of therapeutic products. It operates through the following geographical segments: Switzerland, Europe, USA, Rest of World, and Group. The firm offers products for iron deficiency, nephrology, and cardio-renal therapies. It specializes in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision patient care. The company was founded in 1927 and is headquartered in St. Gallen, Switzerland.

Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland.

Part of CSL Ltd., Vifor Pharma België NV is a pharmaceutical wholesaler based in Antwerp, Belgium. Founded in 2010, the Belgian company specializes in the distribution of pharmaceutical products.

Part of CSL Ltd., Vifor Pharma UK Ltd. is a private company that researches, develops, and manufactures pharmaceutical products. The company is based in Bagshot, UK and was founded in 2010.

Part of CSL Ltd., Vifor France SASU is a global leader in the fields of iron deficiency and treatment of iron deficiency anemia. Vifor France is based in Paris, FR. The French company's history dates back to 1872 when a pharmacist named Caspar Friedrich Hausmann opened a pharmacy in Saint-Gall, Switzerland. Karine Levesque has been the CEO of the private company since 2020.